✦ LIBER ✦

6592 POSTER 5-Fluorouracil/Leucovorin, Oxaliplatin and Irinotecan (FOLFOXIRI) as First-Line Treatment of Advanced Gastric Cancer

✍ Scribed by Grande, C.; Martinez, M.; Villanueva, M.J.; Huidobro, G.; Casal, J.

Book ID: 122505478
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 48 KB
Volume: 47
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(11)71903-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Bevacizumab with FOLFOXIRI (irinotecan,

Bevacizumab with FOLFOXIRI (irinotecan, oxaliplatin, fluorouracil, and folinate) as first-line treatment for metastatic colorectal cancer: a phase 2 trial

✍ Gianluca Masi; Fotios Loupakis; Lisa Salvatore; Lorenzo Fornaro; Chiara Cremolin 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 269 KB

First-line treatment of advanced gastric

First-line treatment of advanced gastric cancer and hepatic dysfunction with oxaliplatin, 5-fluorouracil and cetuximab

✍ Andrés Jesús Muñoz Martín; Virginia Martínez Marín; Juan Luis Arranz Cózar; Luis 📂 Article 📅 2008 🏛 Springer Milan 🌐 Spanish ⚖ 110 KB

Phase III trial of irinotecan plus infus

Phase III trial of irinotecan plus infusional 5-fluorouracil/folinic acid versus irinotecan plus oxaliplatin as first-line treatment of advanced colorectal cancer

✍ Ludwig Fischer von Weikersthal; Andreas Schalhorn; Martina Stauch; Detlef Quietz 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 391 KB

Activity and Safety of Oxaliplatin with

Activity and Safety of Oxaliplatin with Weekly 5-Fluorouracil Bolus and Low-Dose Leucovorin as First-Line Treatment for Advanced Colorectal Cancer

✍ Javier Cassinello; Pilar Escudero; Antonieta Salud; Fernando Marcos; Eduardo Puj 📂 Article 📅 2003 🏛 CIG Media Group, LP. 🌐 English ⚖ 103 KB

Capecitabine plus oxaliplatin (XELOX) ve

Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/leucovorin plus oxaliplatin (FOLFOX-6) as first-line treatment for metastatic colorectal cancer

✍ Michel Ducreux; Jaafar Bennouna; Mohamed Hebbar; Marc Ychou; Gérard Lledo; Thier 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 French ⚖ 440 KB

## Abstract A regimen consisting of 5‐fluorouracil/leucovorin plus oxaliplatin (FOLFOX‐6) is widely used in France in the first‐line treatment of metastatic colorectal cancer (MCRC). The aim of our study was to demonstrate the non‐inferiority of capecitabine plus oxaliplatin (XELOX) __versus__ FOLF

A triplet combination with irinotecan (C

A triplet combination with irinotecan (CPT-11), oxaliplatin (LOHP), continuous infusion 5-fluorouracil and leucovorin (FOLFOXIRI) plus cetuximab as first-line treatment in KRAS wt, metastatic colorectal cancer: a pilot phase II trial

✍ Saridaki, Z; Androulakis, N; Vardakis, N; Vamvakas, L; Kabouraki, E; Kalbakis, K 📂 Article 📅 2012 🏛 Nature Publishing Group 🌐 English ⚖ 242 KB